Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

pharmareview.files.wordpress.com
from pharmareview.files.wordpress.com More from this publisher
02.06.2013 Views

(2006): Santoro D+, Clin Nephrol 66(2), 131 (with codeine) (2005): Daghfous R+, Therapie 60(5), 523 (34%) (2002): Bachmeyer C+, South Med J 95(7), 759 (2002): Litt JZ, Beachwood, OH (personal case) (observation) (patient inadvertently re-challenged herself) (2001): Grant JA+, Ann Allergy Asthma Immunol 87(3), 227 (rare) (2000): Samanta BB, J Assoc Physicians India 47, 464 (1997): de Almeida MA+, Allergy Asthma Proc 18, 313 (1997): Ownby DR, J Allergy Clin Immunol 99, 151 (1985): Cole TO, Clin Exp Dermatol 10, 404 (1985): Stricker BH+, BMJ 291, 938 Vasculitis (1995): Harris A+, Br J Dermatol 133, 790 (1988): Dussarat GV+, Presse Med (French) 17, 1587 Hair Hair – alopecia (1998): Litt JZ, Beachwood, OH (personal case) (observation) Nails Nails – changes (sic) Other Anaphylactoid reactions/Anaphylaxis (2005): Daghfous R+, Therapie 60(5), 523 (2002): Bachmeyer C+, South Med J 95(7), 759 (2002): Liao CM+, Acta Paediatr Taiwan 43(3), 147 (2001): Verma S, Baroda, India (from Internet) (observation) (with ibuprofen) (2000): Ayonrinde OT+, Postgrad Med J. 76, 501 (2000): de Paramo BJ+, Ann Allergy Asthma Immunol 85, 508 (4 patients) (2000): Stephenson I+, Postgrad Med 76, 503 (1999): Kumar RK+, Hosp Med 60, 66 (1999): Spitz E, Ann Allergy Asthma Immunol 82, 591 (1998): Galindo PA+, Allergol Immunopathol (Madr) (Spanish) 26, 199 (1998): Huitema AD+, Hum Exp Toxicol 17, 406 (1990): Van Diem L+, Eur J Clin Pharmacol 38, 389 (1988): Allergy Observer (Janssen Pharmaceutica) 5(7), 1 (1985): Stricker BH+, BMJ 291, 938 Anticonvulsant hypersensitivity syndrome (2006): Gaig P+, J Investig Allergol Clin Immunol 16(5), 321 Death (2002): Sheen CL+, Br J Clin Pharmacol 54(4), 430 (2001): Stevenson R+, Scott Med J 46(3), 84 (overdose) (1988): Minton NA+, Hum Toxicol 7(1), 33 (with phenytoin) Hepatotoxicity (2006): Antoniades CG+, Hepatology 44(1), 34 (2006): Holubek WJ+, Hepatology 43(4), 880 (2006): Lewis JH+, Curr Opin Gastroenterol 22(3), 223 (2006): Liu ZX+, Expert Opin Drug Metab Toxicol 2(4), 493 (2006): Mahadevan SB+, Arch Dis Child 91(7), 598 (2006): Moling O+, Clin Ther 28(5), 755 (2006): Patel KP, NEnglJMed354(20), 2191 (2006): Perkins JD, Liver Transpl 12(4), 682 (2006): Schmidt LE+, Crit Care Med 34(2), 337 (2005): Jaeschke H, Expert Opin Drug Metab Toxicol 1(3), 389 (2005): Peters TS, Toxicol Pathol 33(1), 146 Hypersensitivity (

6 ACETOHEXAMIDE ACETOHEXAMIDE Trade names: Dimelin; Dimelor; Dymelor (Barr) Indications: Non-insulin dependent diabetes type ll Category: Sulfonylurea Half-life: 1–6 hours Clinically important, potentially hazardous interactions with: phenylbutazones Reactions Skin Diaphoresis Eczema Erythema (

6 ACETOHEXAMIDE<br />

ACETOHEXAMIDE<br />

Trade names: Dimelin; Dimelor; Dymelor (Barr)<br />

Indications: Non-insulin dependent diabetes type ll<br />

Category: Sulfonylurea<br />

Half-life: 1–6 hours<br />

Clinically important, potentially hazardous interactions<br />

with: phenylbutazones<br />

Reactions<br />

Skin<br />

Diaphoresis<br />

Eczema<br />

Erythema (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!